CHEMUNG FINANCIAL CORP — Form 8-K
Filed November 3, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Chemung Financial sold ~$245M of low-yielding AFS securities (avg yield ~2%, WAL ~3 yrs) in June 2025, realizing a pre-tax loss of ~$17.5M. Proceeds were deployed to pay down higher-cost wholesale funding and fund loan growth ($268.6M since June 30, 2025). Concurrently, the company raised $45M in subordinated debt to strengthen capital ratios. Results: NIM expanded +50 bps YTD 2026 vs. 2025 (to 3.67%); YTD EPS grew $2.17 to $6.36; YTD ROAA improved +148 bps; YTD ROAE improved +365 bps. Q3 2026 standalone: EPS $2.63, net income $12.7M, NIM 3.74% (up 7 bps QoQ). Company also completed OCC-approved conversion from NY state charter to national charter on October 1, 2026.
Why this rating
Asset-liability restructuring improved profitability metrics materially; +50 bps NIM swing and +$2.17 EPS gain are real gains relative to ~$200M market cap. However, loss on sale ($17.5M) and modest absolute loan growth (7.7% annualized YTD) limit transformational impact.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.